Combating antimicrobial resistance: the silent war

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Antibiotics are losing efficacy due to excessive use, leading to multidrug-resistant (MDR) pathogens.
• Antimicrobial resistance (AMR) is a critical global health issue, increasing mortality and complicating medical procedures.
• The pharmaceutical industry's declining interest in new antibiotic development exacerbates the scarcity of effective treatments.

Purpose of the Study:

• To provide a comprehensive overview of innovative therapeutic strategies against MDR pathogens.
• To highlight novel approaches for combating the growing threat of antimicrobial resistance.
• To analyze the mechanisms, benefits, and drawbacks of emerging antibiotic alternatives.

Main Methods:

• Literature review of contemporary research on novel antimicrobial strategies.
• Analysis of emerging therapeutic avenues targeting multidrug-resistant pathogens.
• Synthesis of information on the action, advantages, and disadvantages of new treatments.

Main Results:

• Several promising innovative therapeutic approaches have been identified to combat MDR pathogens.
• These novel strategies offer potential alternatives to conventional antibiotics.
• The article details the specific mechanisms, benefits, and limitations of each approach.

Conclusions:

• The development of novel strategies is paramount to address the escalating crisis of antimicrobial resistance.
• Innovative therapeutic approaches show promise in overcoming treatment challenges posed by MDR pathogens.
• Further research and development are crucial to expand the pipeline of effective antimicrobial agents.